Japan Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Japan Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Japan respiratory devices market is expected to register a CAGR of 9.6% over the forecast period.

The outbreak of the COVID-19 pandemic has pushed the pharmaceutical industry into action, with a race to develop both therapeutic and preventive drugs. The outbreak of the pandemic has positively impacted the Japanese respiratory devices market. For instance, according to the study titled, "The prevalence of the comorbid respiratory disease among COVID-19 patients, and mortality during the first wave in Japan: A nationwide survey by the Japanese Respiratory Society" published in July 2021, the persons with underlying respiratory disease were more susceptible to COVID-19 infection and mortality. It also stated that among COVID-19 patients, the prevalence of asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung diseases (ILD) was 3.4%, 4.8%, and 1.5%, respectively. Furthermore, it also reported that COVID-19 patients having chronic obstructive pulmonary disease or interstitial lung diseases had relatively high mortality, especially for interstitial lung diseases. Therefore, such instances indicate that the demand for respiratory devices increased during the pandemic in Japan, thereby the market witnessed a considerable growth during COVID-19.

The increasing prevalence of respiratory disorders and technological advancements in the devices are the major driving factors for the market. For instance, as per the study titled, "COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences" published in June 2021, the prevalence of chronic obstructive pulmonary disease (COPD) in Japan in 2020 was 8.6% to 10.9%. Similarly, as per the study titled, "Japanese guidelines for adult asthma 2020" published in September 2020, the mean prevalence of asthma in Japan has increased from 1.0% to 10.0% or higher in children and from 6.0% to 10.0% in adults in 2020 from previous years. Respiratory devices generally help patients in need of support for breathing, removal of carbon dioxide, and therapy to reduce disuse atrophy of abdominal wall muscles. Therefore, increasing cases of respiratory diseases is expected to surge the demand for respiratory devices, thereby propelling the market growth over the forecast period.

However, high cost of equipment are likely to hinder the market growth over the forecast period.

Key Market TrendsInhalers Segment is Expected to Witness Growth Over the Forecast Period

An inhaler is a device used to deliver medication to the lungs and airways. It is mainly used to treat or prevent respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. Inhalers are medications that are inhaled through the mouth and into the lungs which helps to relax the muscles that tighten around the airways. Inhalers help to open up the airways and allow more air to move in and out of the lungs and help the patient to breathe more easily.

The increasing cases of respiratory diseases such as hay fever and chronic obstructive pulmonary disease (COPD) are the major factors propelling the segment's growth. In Japan, the most prevalent respiratory allergy in the country is Hay fever, which is caused due to the cedar pollen spread throughout the country. For instance, according to the article published in January 2022, it is estimated that 25.0 million people are found suffering from hay fever in Japan. In addition, increasing respiratory syncytial virus infections among children in Japan is also one of the major drivers propelling the market growth. For instance, according to the study titled, "Disease burden of respiratory syncytial virus infection in the pediatric population in Japan" published in February 2022, respiratory syncytial virus (RSV) is one of the most common causes of lower respiratory tract infections in children of age 5 years and above and is associated with long-term respiratory morbidities such as recurrent wheezing and asthma, decreased lung function, and allergic sensitization. Respiratory syncytial virus imposes a significant burden on the Japanese healthcare system. Therefore the increasing number of such cases is anticipated to increase the demand for inhalers in Japan, thereby propelling the segment growth over the forecast period.

Competitive Landscape

The Japan respiratory devices market is moderately competitive and fragmented in nature with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GE Healthcare, Getinge AB, Terumo Corporation, and Koninklijke Philips NV among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.